{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:05:39Z","timestamp":1768446339039,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"DOI":"10.1186\/s13018-025-05537-1","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T03:55:57Z","timestamp":1740801357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A novel mechanism in regulating drug sensitivity, growth, and apoptosis of bortezomib-resistant multiple myeloma cells: the USP4\/KLF2\/HMGA2 cascade"],"prefix":"10.1186","volume":"20","author":[{"given":"Ziyi","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengqun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mufang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinjingwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"issue":"5","key":"5537_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, Tuazon S, Gopal AK, Libby EN. Diagnosis and management of multiple myeloma: a review. JAMA. 2022;327(5):464\u201377.","journal-title":"JAMA"},{"issue":"9","key":"5537_CR2","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/ajh.27422","volume":"99","author":"SV Rajkumar","year":"2024","unstructured":"Rajkumar SV. Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol. 2024;99(9):1802\u201324.","journal-title":"Am J Hematol"},{"issue":"8","key":"5537_CR3","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/ajh.27327","volume":"99","author":"MJ Rees","year":"2024","unstructured":"Rees MJ, Kumar S. High-risk multiple myeloma: redefining genetic, clinical, and functional high-risk disease in the era of molecular medicine and immunotherapy. Am J Hematol. 2024;99(8):1560\u201375.","journal-title":"Am J Hematol"},{"issue":"1","key":"5537_CR4","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1186\/s13018-023-04399-9","volume":"18","author":"S Long","year":"2023","unstructured":"Long S, Long S, He H, Luo L, Liu M, Ding T. Exosomal miR-182 derived from bone marrow mesenchymal stem cells drives carfilzomib resistance of multiple myeloma cells by targeting SOX6. J Orthop Surg Res. 2023;18(1):937.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"5537_CR5","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s13018-023-03835-0","volume":"18","author":"P Zeng","year":"2023","unstructured":"Zeng P, Wang F, Long X, Cao Y, Wen F, Li J, Luo Z. CPEB2 enhances cell growth and angiogenesis by upregulating ARPC5 mRNA stability in multiple myeloma. J Orthop Surg Res. 2023;18(1):384.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"5537_CR6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s13018-023-03832-3","volume":"18","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Duan H, Yang W, Liu H, Tao X, Zhang Y. Circ_0005615 restrains the progression of multiple myeloma through modulating mir-331-3p and IGF1R regulatory cascade. J Orthop Surg Res. 2023;18(1):356.","journal-title":"J Orthop Surg Res"},{"issue":"21","key":"5537_CR7","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1182\/blood.2023022470","volume":"142","author":"LE Lucca","year":"2023","unstructured":"Lucca LE. Multiple myeloma treatment: one bridge closer. Blood. 2023;142(21):1763\u20134.","journal-title":"Blood"},{"issue":"5","key":"5537_CR8","doi-asserted-by":"publisher","first-page":"961","DOI":"10.2174\/1570180820666230125102954","volume":"21","author":"D Abhijit","year":"2024","unstructured":"Abhijit D, Rupa M, Avijit M, Rajesh S, Shikha S. <i\u2009>\u2009in silico identification of HDAC inhibitors for multiple myeloma: a structure-based virtual screening, drug likeness, ADMET profiling, Molecular Docking, and Molecular Dynamics Simulation Study<\/i\u2009>. Lett Drug Des Discovery. 2024;21(5):961\u201378.","journal-title":"Lett Drug Des Discovery"},{"issue":"4","key":"5537_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1056\/NEJMoa2312054","volume":"390","author":"P Sonneveld","year":"2024","unstructured":"Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, Hulin C, Antonioli E, Leleu X, Mangiacavalli S, et al. Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for multiple myeloma. N Engl J Med. 2024;390(4):301\u201313.","journal-title":"N Engl J Med"},{"key":"5537_CR10","doi-asserted-by":"crossref","unstructured":"Tang X, Wang P, Zhang R, Watanabe I, Chang E, Vinayachandran V, Nayak L, Lapping S, Liao S, Madera A, et al. KLF2 regulates neutrophil activation and thrombosis in cardiac hypertrophy and heart failure progression. J Clin Investig. 2022;132(3).","DOI":"10.1172\/JCI147191"},{"issue":"15","key":"5537_CR11","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/CIRCULATIONAHA.123.064735","volume":"149","author":"IA Tamargo","year":"2024","unstructured":"Tamargo IA, Baek KI, Xu C, Kang DW, Kim Y, Andueza A, Williams D, Demos C, Villa-Roel N, Kumar S, et al. HEG1 protects against atherosclerosis by regulating stable Flow-Induced KLF2\/4 expression in endothelial cells. Circulation. 2024;149(15):1183\u2013201.","journal-title":"Circulation"},{"key":"5537_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.09.014","volume":"522","author":"Y Lu","year":"2021","unstructured":"Lu Y, Qin H, Jiang B, Lu W, Hao J, Cao W, Du L, Chen W, Zhao X, Guo H. KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma. Cancer Lett. 2021;522:1\u201313.","journal-title":"Cancer Lett"},{"issue":"5","key":"5537_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/cjp2.325","volume":"9","author":"J Li","year":"2023","unstructured":"Li J, Jiang JL, Chen YM, Lu WQ. KLF2 inhibits colorectal cancer progression and metastasis by inducing ferroptosis via the PI3K\/AKT signaling pathway. J Pathol Clin Res. 2023;9(5):423\u201335.","journal-title":"J Pathol Clin Res"},{"issue":"16","key":"5537_CR14","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1038\/s41388-021-01753-1","volume":"40","author":"FC Huo","year":"2021","unstructured":"Huo FC, Zhu ZM, Zhu WT, Du QY, Liang J, Mou J. METTL3-mediated m(6)a methylation of SPHK2 promotes gastric cancer progression by targeting KLF2. Oncogene. 2021;40(16):2968\u201381.","journal-title":"Oncogene"},{"key":"5537_CR15","doi-asserted-by":"publisher","first-page":"1172641","DOI":"10.3389\/fimmu.2023.1172641","volume":"14","author":"J Wittner","year":"2023","unstructured":"Wittner J, Schuh W. Kr\u00fcppel-like factor 2: a central regulator of B cell differentiation and plasma cell homing. Front Immunol. 2023;14:1172641.","journal-title":"Front Immunol"},{"issue":"5","key":"5537_CR16","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s11845-021-02781-2","volume":"191","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang L, Gong J. Relation among EGFL7, ITGB3, and KLF2 and their clinical implication in multiple myeloma patients: a prospective study. Ir J Med Sci. 2022;191(5):1995\u20132001.","journal-title":"Ir J Med Sci"},{"issue":"6","key":"5537_CR17","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1182\/bloodadvances.2019001002","volume":"4","author":"Y Salama","year":"2020","unstructured":"Salama Y, Heida AH, Yokoyama K, Takahashi S, Hattori K, Heissig B. The EGFL7-ITGB3-KLF2 axis enhances survival of multiple myeloma in preclinical models. Blood Adv. 2020;4(6):1021\u201337.","journal-title":"Blood Adv"},{"key":"5537_CR18","doi-asserted-by":"publisher","first-page":"10258","DOI":"10.1038\/ncomms10258","volume":"7","author":"H Ohguchi","year":"2016","unstructured":"Ohguchi H, Hideshima T, Bhasin MK, Gorgun GT, Santo L, Cea M, Samur MK, Mimura N, Suzuki R, Tai YT, et al. The KDM3A-KLF2-IRF4 axis maintains myeloma cell survival. Nat Commun. 2016;7:10258.","journal-title":"Nat Commun"},{"issue":"24","key":"5537_CR19","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1182\/blood-2014-01-547448","volume":"123","author":"L Nayak","year":"2014","unstructured":"Nayak L, Shi H, Atkins GB, Lin Z, Schmaier AH, Jain MK. The thromboprotective effect of bortezomib is dependent on the transcription factor kruppel-like factor 2 (KLF2). Blood. 2014;123(24):3828\u201331.","journal-title":"Blood"},{"issue":"1","key":"5537_CR20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, Lu B, Fan Y, Liu Z, Chen X, et al. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer. 2024;23(1):148.","journal-title":"Mol Cancer"},{"key":"5537_CR21","doi-asserted-by":"publisher","first-page":"595159","DOI":"10.3389\/fcell.2021.595159","volume":"9","author":"B Hu","year":"2021","unstructured":"Hu B, Zhang D, Zhao K, Wang Y, Pei L, Fu Q, Ma X. Spotlight on USP4: structure, function, and Regulation. Front cell Dev Biology. 2021;9:595159.","journal-title":"Front cell Dev Biology"},{"issue":"8","key":"5537_CR22","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1080\/15384101.2023.2170521","volume":"22","author":"CJ Chen","year":"2023","unstructured":"Chen CJ, Huang JY, Huang JQ, Deng JY, Shangguan XH, Chen AZ, Chen LT, Wu WH. Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4. Cell Cycle (Georgetown Tex). 2023;22(8):986\u20131004.","journal-title":"Cell Cycle (Georgetown Tex)"},{"key":"5537_CR23","doi-asserted-by":"publisher","first-page":"106732","DOI":"10.1016\/j.phrs.2023.106732","volume":"190","author":"M Hashemi","year":"2023","unstructured":"Hashemi M, Rashidi M, Hushmandi K, Ten Hagen TLM, Salimimoghadam S, Taheriazam A, Entezari M, Falahati M. HMGA2 regulation by miRNAs in cancer: affecting cancer hallmarks and therapy response. Pharmacol Res. 2023;190:106732.","journal-title":"Pharmacol Res"},{"issue":"9","key":"5537_CR24","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1172\/JCI99257","volume":"128","author":"S Rizzolio","year":"2018","unstructured":"Rizzolio S, Cagnoni G, Battistini C, Bonelli S, Isella C, Van Ginderachter JA, Bernards R, Di Nicolantonio F, Giordano S, Tamagnone L. Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies. J Clin Investig. 2018;128(9):3976\u201390.","journal-title":"J Clin Investig"},{"issue":"2","key":"5537_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","volume":"28","author":"PE Cockram","year":"2021","unstructured":"Cockram PE, Kist M, Prakash S, Chen SH, Wertz IE, Vucic D. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ. 2021;28(2):591\u2013605.","journal-title":"Cell Death Differ"},{"key":"5537_CR26","doi-asserted-by":"publisher","first-page":"103949","DOI":"10.1016\/j.jprot.2020.103949","volume":"229","author":"P Sulkshane","year":"2020","unstructured":"Sulkshane P, Duek I, Ram J, Thakur A, Reis N, Ziv T, Glickman MH. Inhibition of proteasome reveals basal mitochondrial ubiquitination. J Proteom. 2020;229:103949.","journal-title":"J Proteom"},{"key":"5537_CR27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12935-020-01391-9","volume":"20","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhou L, Lu J, Jiang B, Liu C, Guo J. USP4 function and multifaceted roles in cancer: a possible and potential therapeutic target. Cancer Cell Int. 2020;20:298.","journal-title":"Cancer Cell Int"},{"issue":"11","key":"5537_CR28","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41419-023-06259-0","volume":"14","author":"H Zhang","year":"2023","unstructured":"Zhang H, Han Y, Xiao W, Gao Y, Sui Z, Ren P, Meng F, Tang P, Yu Z. USP4 promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting TAK1. Cell Death Dis. 2023;14(11):730.","journal-title":"Cell Death Dis"},{"issue":"5","key":"5537_CR29","doi-asserted-by":"publisher","first-page":"e22900","DOI":"10.1096\/fj.202201337RRR","volume":"37","author":"SI Yun","year":"2023","unstructured":"Yun SI, Kwak C, Lee SY, Shin S, Oh C, Kim JS, Rhee HW, Kim KK. Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2023;37(5):e22900.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"issue":"8","key":"5537_CR30","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/s41416-020-01237-1","volume":"124","author":"R Kumari","year":"2021","unstructured":"Kumari R, Majumder MM, Lievonen J, Silvennoinen R, Anttila P, Nupponen NN, Lehmann F, Heckman CA. Prognostic significance of esterase gene expression in multiple myeloma. Br J Cancer. 2021;124(8):1428\u201336.","journal-title":"Br J Cancer"},{"issue":"2","key":"5537_CR31","doi-asserted-by":"publisher","first-page":"963","DOI":"10.7150\/thno.65411","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, Wang J, Zhao J, Wang H, Chen J, Wu J. HMGA2 facilitates colorectal cancer progression via STAT3-mediated tumor-associated macrophage recruitment. Theranostics. 2022;12(2):963\u201375.","journal-title":"Theranostics"},{"issue":"1","key":"5537_CR32","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1186\/s12885-021-09020-y","volume":"21","author":"L Jiang","year":"2021","unstructured":"Jiang L, Zhang Y, Guo L, Liu C, Wang P, Ren W. Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2\/mTOR\/P-gp pathway. BMC Cancer. 2021;21(1):1290.","journal-title":"BMC Cancer"},{"issue":"2","key":"5537_CR33","first-page":"133","volume":"34","author":"N Yyusnita","year":"2012","unstructured":"Yyusnita N, Zakiah I, Chang KM, Purushotaman VS, Zubaidah Z, Jamal R. MicroRNA (miRNA) expression profiling of peripheral blood samples in multiple myeloma patients using microarray. Malays J Pathol. 2012;34(2):133\u201343.","journal-title":"Malays J Pathol"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-05537-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-025-05537-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-05537-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T03:56:01Z","timestamp":1740801361000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-025-05537-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5537"],"URL":"https:\/\/doi.org\/10.1186\/s13018-025-05537-1","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"220"}}